1H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings

No abstract is available for this paper.

• Publication year

  2006

• Venue

  European Radiology

• Publication date

  2006-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00330-005-2839-1PMID 16028056
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of the human brain in primary progressive multiple sclerosis with mapping of the spatial distributions using 1H MR spectroscopy and diffusion tensor imaging

  2005cited by this paper
• Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis

  2004cited by this paper
• Water content and myelin water fraction in multiple sclerosis

  2004cited by this paper
• Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis.

  2004cited by this paper
• Diffusely elevated cerebral choline and creatine in relapsing‐remitting multiple sclerosis

  2003influential reference
• Thalamic neurodegeneration in relapsing-remitting multiple sclerosis

  2003cited by this paper
• Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis.

  2003cited by this paper
• Evidence of Wallerian degeneration in normal appearing white matter in the early stages of relapsing-remitting multiple sclerosis

  2003cited by this paper
• Brain changes with aging: MR spectroscopy at supraventricular plane shows differences between women and men.

  2003cited by this paper
• Brain metabolite profiles of T1-hypointense lesions in relapsing-remitting multiple sclerosis.

  2003cited by this paper
• Comparison of longitudinal metabolite relaxation times in different regions of the human brain at 1.5 and 3 Tesla

  2003cited by this paper
• Metabolic differences between multiple sclerosis subtypes measured by quantitative MR spectroscopy

  2002influential reference
• Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis.

  2002cited by this paper
• Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy.

  2002cited by this paper
• 1H chemical shift imaging characterization of human brain tumor and edema

  2002cited by this paper
• A proton magnetic resonance spectroscopy study of age-related changes in frontal lobe metabolite concentrations.

  2001cited by this paper
• Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

  2001cited by this paper
• 1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS

  2000cited by this paper
• Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques: absolute metabolic values over 2 years during a clinical pharmacological study.

  2000cited by this paper
• Proton magnetic resonance spectroscopy in primary and secondary progressive multiple sclerosis

  2000cited by this paper
• 1H Magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis

  1999cited by this paper
• 1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd‐contrast

  1997cited by this paper
• Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra.

  1993cited by this paper

• Magnetic resonance spectroscopy for discriminating primary angiitis of the central nervous system from gliomas and lymphomas

  2025cites this paper
• Hand–foot coordination is significantly influenced by motion direction in individuals with autism spectrum disorder

  2022cites this paper
• In vivo evidence of differential frontal cortex metabolic abnormalities in progressive and relapsing‐remitting multiple sclerosis

  2021cites this paper
• The Creatine Transporter Unfolded: A Knotty Premise in the Cerebral Creatine Deficiency Syndrome

  2020cites this paper
• Quantifying the Metabolic Signature of Multiple Sclerosis by in vivo Proton Magnetic Resonance Spectroscopy: Current Challenges and Future Outlook in the Translation From Proton Signal to Diagnostic Biomarker

  2019cites this paper
• Monitoring Progressive Multiple Sclerosis with Novel Imaging Techniques

  2018influential citation
• Febuxostat ameliorates secondary progressive experimental autoimmune encephalomyelitis by restoring mitochondrial energy production in a GOT2-dependent manner

  2017cites this paper
• A Comparison of N-acetyl Aspartate Concentrations between Two Main Subtypes of Multiple Sclerosis using Magnetic Resonance Spectroscopy Imaging

  2017influential citation
• University of Groningen Diagnostic evaluation of developmental delay

  2017cites this paper
• The prognostic value of proton magnetic resonance spectroscopy in term newborns treated with therapeutic hypothermia following asphyxia.

  2017cites this paper
• Diagnostic value of MRS-quantified brain tissue lactate level in identifying children with mitochondrial disorders

  2016cites this paper
• Longitudinal monitoring of metabolic alterations in cuprizone mouse model of multiple sclerosis using 1H-magnetic resonance spectroscopy

  2015cites this paper
• Molecular Imaging Using Magnetic Resonance Spectroscopy in Neurology: The Past, the Present, and the Future

  2014cites this paper
• Cortical N-acetyl aspartate is a predictor of long-term clinical disability in multiple sclerosis

  2014cites this paper
• The Neurodegenerative Process in Multiple Sclerosis and the Possible Neuroprotective Effect of Treatment with β-Interferon 1a (Avonex)

  2013cites this paper
• 1H magnetic resonance spectroscopy in multiple sclerosis and related disorders.

  2013cites this paper
• [Neurodegenerative process in multiple sclerosis and a possible neuroprotective effect of β-interferon 1a (avonex)].

  2012cites this paper
• MR Spectroscopy in Multiple Sclerosis - A New Piece of the Puzzle or Just a New Puzzle

  2012influential citation
• Shifting imaging targets in multiple sclerosis: From inflammation to neurodegeneration

  2012cites this paper
• Hippocampal dysfunction effects on context memory: possible etiology for posttraumatic stress disorder.

  2012cites this paper
• Cerebral metabolism, magnetic resonance spectroscopy and cognitive dysfunction in early multiple sclerosis: an exploratory study

  2012cites this paper
• Progressive multiple sclerosis and gray matter pathology: an MRI perspective.

  2011cites this paper
• New diagnostic developments to prevent unnecessary invasive procedures in breast cancer diagnostic work-up

  2011cites this paper
• The prognostic value of multivoxel magnetic resonance spectroscopy determined metabolite levels in white and grey matter brain tissue for adverse outcome in term newborns following perinatal asphyxia

  2011cites this paper
• Diagnostic evaluation of developmental delay

  2011cites this paper
• Neuromyélite optique de Devic, troubles cognitifs et imagerie cérébrale par résonance magnétique

  2011cites this paper
• Quantitative multivoxel proton chemical shift imaging of the breast.

  2010cites this paper
• Imaging biomarkers in multiple sclerosis

  2010cites this paper
• MR Imaging of Gray Matter Involvement in Multiple Sclerosis: Implications for Understanding Disease Pathophysiology and Monitoring Treatment Efficacy

  2010cites this paper
• Cerebral metabolic changes in neurologically presymptomatic patients undergoing haemodialysis: in vivo proton MR spectroscopic findings

  2010cites this paper
• Magnetic resonance imaging to assess gray matter damage in multiple sclerosis

  2010cites this paper
• Advanced magnetic resonance imaging techniques to better understand multiple sclerosis

  2010cites this paper
• The use of proton magnetic resonance spectroscopy in PTSD research--meta-analyses of findings and methodological review.

  2010cites this paper
• Reduced NAA-Levels in the NAWM of Patients with MS Is a Feature of Progression. A Study with Quantitative Magnetic Resonance Spectroscopy at 3 Tesla

  2010cites this paper
• Quantitative Cervical Spinal Cord 3T Proton MR Spectroscopy in Multiple Sclerosis

  2010cites this paper
• Quantitative multivoxel proton spectroscopy of the brain in developmental delay

  2009cites this paper
• Magnetic resonance imaging and proton magnetic resonance spectroscopy of the brain in the diagnostic evaluation of developmental delay.

  2009cites this paper
• MRSI evidence for cortical gray matter pathology that is independent of cerebral white matter lesion load in patients with secondary progressive multiple sclerosis

  2009cites this paper
• Proton magnetic resonance spectroscopy in multiple sclerosis.

  2009cites this paper
• Deep gray matter atrophy in multiple sclerosis: a tensor based morphometry.

  2009cites this paper
• Fluoxetine as disease modifying treatment in multiple sclerosis: rationale, evaluation of the use of MRI to monitor treatment, and preliminary findings

  2009cites this paper
• Spectroscopic Imaging of Breast Cancer

  2009cites this paper
• Metabonomics Based on Pattern Recognition Methods in 1 H in vivo MRS in Differentiation Metabolic Profiles of Multiple Sclerosis Subtypes

  2009cites this paper
• white matter lesion load in patients with secondary progressive multiple sclerosis

  2009cites this paper
• Magnetic resonance techniques to quantify tissue damage, tissue repair, and functional cortical reorganization in multiple sclerosis.

  2009cites this paper
• MR spectroscopy of the brain in Leigh syndrome.

  2008cites this paper
• Impact of fluoxetine on the human brain in multiple sclerosis as quantified by proton magnetic resonance spectroscopy and diffusion tensor imaging.

  2008cites this paper
• Long‐Term Study of Brain 1H‐MRS Study in Multiple Sclerosis: Effect of Glatiramer Acetate Therapy on Axonal Metabolic Function and Feasibility of Long‐Term 1H‐MRS Monitoring in Multiple Sclerosis

  2008cites this paper
• Quantitative multivoxel H-1 MR spectroscopy of the brain in children with acute liver failure

  2008cites this paper
• Longitudinal magnetic resonance spectroscopic imaging of primary progressive multiple sclerosis patients treated with glatiramer acetate: multicenter study

  2008cites this paper
• Quantitative multivoxel 1H MR spectroscopy of the brain in children with acute liver failure

  2008cites this paper
• [Total brain T2-hyperintense lesion-volume and the axonal damage in the normal-appearing white matter of brainstem in early lapsing-remitting multiple sclerosis].

  2007cites this paper
• Inflammatory demyelination and neurodegeneration in early multiple sclerosis.

  2007cites this paper
• Occipital Proton Magnetic Resonance Spectroscopy (1H-MRS) Reveals Normal Metabolite Concentrations in Retinal Visual Field Defects

  2007cites this paper
• Successful treatment of a guanidinoacetate methyltransferase deficient patient: findings with relevance to treatment strategy and pathophysiology.

  2007cites this paper
• MR spectroscopy and diffusion tensor imaging of the brain in congenital muscular dystrophy with merosin deficiency: metabolite level decreases, fractional anisotropy decreases, and apparent diffusion coefficient increases in the white matter.

  2007cites this paper
• High cerebral guanidinoacetate and variable creatine concentrations in argininosuccinate synthetase and lyase deficiency: implications for treatment?

  2006cites this paper
• Relationships between brain water content and diffusion tensor imaging parameters (apparent diffusion coefficient and fractional anisotropy) in multiple sclerosis

  2006cites this paper
• Diffusion tensor imaging and magnetic resonance spectroscopy of the brain in a patient with sturge-weber syndrome

  2006cites this paper
• Diagnostic evaluation of developmental delay

  year unknowncites this paper